Skip to content
Clinical Trials – home

Benign neoplasm of thyroid gland Treatment

1 / 1 trials open to patients1 country

In short

Benign thyroid nodules—non-cancerous lumps in the thyroid gland—are surprisingly common, yet most people who have them never experience symptoms or require aggressive treatment. Understanding the available approaches, from simple observation to newer minimally invasive techniques and, when necessary, surgery, can help patients and their doctors make informed decisions about managing these growths.

Key points

  • Over ninety percent of thyroid nodules detected in adults are benign (non-cancerous), and many never cause symptoms or require treatment beyond periodic monitoring.
  • Active surveillance with regular ultrasound examinations and blood tests is often the recommended approach for small, symptom-free benign nodules that remain stable over time.
  • Surgery becomes necessary when benign nodules grow to four centimeters or larger, cause breathing or swallowing difficulties, produce excess thyroid hormone, or create significant cosmetic concerns.
  • Radiofrequency ablation offers a minimally invasive alternative to surgery for selected patients, using heat to shrink nodules while avoiding general anesthesia, surgical scars, and thyroid hormone deficiency.
  • Studies comparing radiofrequency ablation to surgery show that ablation results in fewer complications, preserves normal thyroid function, and allows faster recovery, though it is not suitable for all nodule types.
  • Ethanol ablation can effectively treat fluid-filled cystic thyroid nodules by draining the cyst and injecting alcohol to prevent recurrence, offering another non-surgical option for appropriate candidates.
  • Traditional thyroid surgery remains the most definitive treatment but carries risks including voice changes from nerve injury, parathyroid gland damage affecting calcium levels, and need for lifelong thyroid hormone replacement.
  • Treatment decisions should consider nodule characteristics, symptom severity, patient preferences, and availability of specialized procedures, with individualized approaches providing the best outcomes for each person.

Understanding Treatment Goals for Benign Thyroid Growths

When a person receives a diagnosis of a benign thyroid nodule, the first question is often about treatment. The good news is that more than ninety percent of thyroid nodules detected in adults turn out to be non-cancerous, meaning they pose little threat to overall health. The main goals of managing these benign growths focus on relieving any symptoms they might cause, such as difficulty swallowing or breathing, addressing cosmetic concerns when the nodule creates a visible lump in the neck, and preventing complications from nodules that produce excessive thyroid hormone. For many people, treatment might simply mean regular monitoring to ensure the nodule isn't growing or changing in a worrying way.

The approach to treatment depends heavily on individual circumstances. Factors such as the size of the nodule, whether it causes symptoms, its location within the thyroid gland, and whether it affects thyroid hormone levels all play a role in determining the best path forward. Some nodules remain stable for years and never require any intervention beyond periodic ultrasound examinations and blood tests. Others may grow large enough to press on nearby structures in the neck, making surgery or other treatments necessary. Importantly, each patient's preferences and concerns matter greatly in deciding which option suits them best.

Medical guidelines from professional societies recommend a stepwise approach to evaluating and managing thyroid nodules. After initial diagnosis through physical examination and imaging—usually ultrasound—doctors measure thyroid function through blood tests. If a nodule appears suspicious or meets certain size criteria, a fine needle aspiration biopsy (a procedure where a thin needle removes a small sample of cells for examination under a microscope) helps confirm that the growth is benign. Once confirmed as non-cancerous, treatment options range from watchful waiting to various interventions, both established and emerging.

Standard Treatment Approaches for Benign Thyroid Nodules

For many patients with benign thyroid nodules, the standard recommended approach is active surveillance, also called watchful waiting or observation. This strategy involves no immediate treatment but includes regular follow-up visits with a healthcare provider. During these visits, the doctor performs physical examinations, orders thyroid function blood tests, and repeats ultrasound imaging—typically after about one year initially, and then at intervals determined by how stable the nodule appears. This conservative approach makes sense because many benign nodules never grow significantly or cause problems. If a nodule remains unchanged over several years, it may never require any treatment whatsoever.

Some doctors prescribe thyroid hormone therapy, usually in the form of levothyroxine (a synthetic version of the hormone thyroxine that the thyroid naturally produces), to patients with benign nodules. The theory behind this practice is that giving extra thyroid hormone can lower the production of thyroid-stimulating hormone (TSH) by the pituitary gland in the brain. Since TSH stimulates thyroid tissue growth, reducing it might theoretically slow or prevent nodule enlargement. However, medical evidence supporting this approach remains limited, and many experts question whether it truly affects nodule growth. Despite this uncertainty, the practice continues in some clinical settings, particularly when patients are anxious about their nodules and want to feel they are doing something active to address them.

Surgery remains the most definitive treatment for benign thyroid nodules, particularly when they cause clear problems. Doctors recommend surgical removal in several situations: when a nodule grows large enough to create a visible mass in the neck that bothers the patient cosmetically; when it produces symptoms by pressing on the windpipe (causing breathing difficulties) or the esophagus (causing swallowing problems); when it produces excessive thyroid hormone leading to hyperthyroidism (a condition where too much thyroid hormone speeds up body functions, causing symptoms like rapid heartbeat, weight loss, nervousness, and sweating); or when biopsy results are unclear and cannot definitively rule out cancer. Surgery can involve removing just the half of the thyroid gland containing the nodule (called a thyroid lobectomy) or removing the entire thyroid gland (called a total thyroidectomy). The choice depends on factors like nodule size, location, and whether nodules exist in both halves of the gland.

Traditional thyroid surgery is generally safe when performed by experienced surgeons, but it does carry certain risks. The most significant concern involves the recurrent laryngeal nerve, which controls the vocal cords and runs very close to the thyroid gland. Damage to this nerve, though rare with skilled surgeons, can cause permanent voice changes or hoarseness. Surgery also risks injuring the parathyroid glands, four tiny glands behind the thyroid that control calcium levels in the body. Injury to these glands can cause low calcium levels, requiring lifelong calcium supplementation. After total thyroidectomy, patients need lifelong thyroid hormone replacement medication, since their body can no longer produce this essential hormone. The surgery typically requires general anesthesia and leaves a visible scar across the front of the neck, though surgeons try to minimize its appearance.

For certain types of benign thyroid nodules, particularly those that are primarily fluid-filled (called cystic nodules), a procedure called ethanol ablation offers a non-surgical option. During this procedure, performed under ultrasound guidance to visualize the nodule, the doctor first drains the fluid from the cyst using a needle. Immediately afterward, ethanol (pure alcohol) is injected into the empty space. The ethanol causes the walls of the cyst to stick together, preventing it from refilling with fluid and recurring. This technique works best for cysts that measure at least two centimeters in diameter and consist of one or possibly two large fluid-filled chambers, rather than multiple small compartments arranged in a honeycomb pattern. Ethanol ablation is relatively quick, can be performed in an office setting, and avoids the risks and recovery time associated with surgery. It is available at select medical centers, often performed by interventional radiologists or surgeons with special training in this technique.

Emerging and Innovative Treatment Approaches

Over recent years, a newer minimally invasive technique called radiofrequency ablation (RFA) has gained attention as an alternative to surgery for selected benign thyroid nodules. This procedure uses heat generated by radio waves to destroy nodule tissue. During RFA, performed under local anesthesia with the patient awake, the doctor inserts a thin electrode (a special type of needle) into the nodule, guided by ultrasound imaging to ensure precise placement. The electrode sends out an alternating electrical current at radio wave frequencies, which heats and destroys the tissue in the nodule. The goal is to shrink the nodule significantly, relieving symptoms and improving appearance without the need for general anesthesia or surgical incisions.

RFA works best for solid nodules or those with some fluid-filled components. Not every nodule is suitable for this treatment—the decision depends on multiple factors including the nodule's size, location within the thyroid, its appearance on ultrasound, and the specific symptoms it causes. Nodules located on the back surface of the thyroid gland near the vocal cord nerve pose particular risks, since the heat from RFA could potentially damage this important nerve. Similarly, nodules very close to major blood vessels like the carotid artery require extra caution. Careful patient selection and thorough pre-treatment evaluation are essential for safe and effective outcomes.

Studies comparing RFA to traditional surgery have shown promising results. In one research study involving two hundred patients treated with surgery and an equal number treated with RFA, both approaches effectively reduced nodule size. However, RFA resulted in significantly fewer complications compared to surgery (only one percent of RFA patients experienced complications versus six percent of surgery patients). Nodules treated with RFA shrank dramatically, with average volume decreasing from 5.4 milliliters before treatment to just 0.4 milliliters twelve months later. Another major advantage of RFA is that it does not cause hypothyroidism, whereas over seventy percent of patients who underwent surgery developed low thyroid function requiring lifelong hormone replacement. Additionally, RFA patients typically experienced shorter hospital stays and faster recovery times.

Currently, RFA is available at a limited number of medical centers, primarily in the United Kingdom and other countries. Several National Health Service hospitals in the UK now offer this procedure, including Freeman Hospital in Newcastle, Guy's Hospital and Hammersmith Hospital in London, Royal Berkshire Hospital in Reading, and Royal Bournemouth Hospital, among others. A clinical trial is underway in certain UK centers where patients with benign thyroid nodules are randomly assigned to receive either traditional surgery or RFA, which will help establish more definitive evidence about the relative benefits of each approach. For patients interested in RFA, obtaining a referral letter from their regular doctor is necessary to be considered for treatment at these specialized centers.

Another thermal ablation technique being explored is microwave ablation, which works on similar principles to RFA but uses microwave energy instead of radio waves to generate heat and destroy nodule tissue. Additionally, researchers are investigating laser ablation, where laser energy heats and destroys thyroid nodule tissue. These techniques are less widely available than RFA but may offer advantages in specific situations. All thermal ablation methods share the benefits of being minimally invasive, preserving normal thyroid tissue and function, avoiding general anesthesia, and leaving no visible scars—making them attractive alternatives to surgery for appropriately selected patients.

The field of benign thyroid nodule treatment continues to evolve. Researchers are working to refine patient selection criteria for minimally invasive procedures, identify which nodules respond best to different treatments, and develop better techniques to minimize complications. Ongoing clinical trials comparing different treatment approaches will provide more robust evidence to guide treatment decisions in the future. Some research also explores whether certain medications or supplements might slow nodule growth, though currently no pharmacological treatments have proven consistently effective for shrinking benign thyroid nodules.

Most Common Treatment Methods

  • Active Surveillance (Watchful Waiting)
    • Regular monitoring with physical examinations, thyroid function blood tests, and ultrasound imaging, typically starting one year after diagnosis
    • Appropriate for nodules that don't cause symptoms and remain stable over time
    • May be continued indefinitely if nodules show no concerning changes
  • Thyroid Hormone Therapy
    • Prescription of levothyroxine (synthetic thyroid hormone) to suppress thyroid-stimulating hormone production
    • Theoretical goal of slowing nodule growth, though evidence of effectiveness is limited
    • Sometimes used when patients desire active treatment for benign nodules
  • Surgical Treatment
    • Thyroid lobectomy: removal of the half of the thyroid containing the nodule
    • Total thyroidectomy: removal of the entire thyroid gland
    • Indicated for large nodules (especially those four centimeters or larger), symptomatic nodules causing breathing or swallowing difficulties, nodules producing excess hormone, or when cancer cannot be ruled out
    • Requires general anesthesia and leaves a neck scar
    • Carries risks including voice changes from nerve injury, parathyroid gland damage, and need for lifelong hormone replacement after total thyroidectomy
  • Ethanol Ablation
    • Draining fluid from cystic (fluid-filled) thyroid nodules followed by injection of ethanol (alcohol)
    • Causes cyst walls to adhere together, preventing recurrence
    • Performed under ultrasound guidance in an office setting
    • Works best for large cysts (two centimeters or greater) with one or two chambers
    • Available at select medical centers, performed by interventional radiologists or specially trained surgeons
  • Radiofrequency Ablation (RFA)
    • Minimally invasive procedure using heat from radio waves to destroy nodule tissue
    • Performed under local anesthesia with ultrasound guidance
    • Electrode needle inserted into nodule generates heat to shrink the growth
    • Suitable for solid or partially cystic benign nodules confirmed by biopsy
    • Studies show significant nodule shrinkage with fewer complications than surgery
    • Does not cause hypothyroidism, preserves normal thyroid function
    • Currently available at limited number of specialized centers
    • Clinical trials ongoing to compare effectiveness with traditional surgery
  • Other Thermal Ablation Techniques
    • Microwave ablation: uses microwave energy to heat and destroy nodule tissue
    • Laser ablation: uses laser energy to destroy nodule tissue
    • Less widely available but under investigation as alternatives to RFA and surgery

Did you know?

  1. Ultrasound studies reveal that between twenty and seventy-six percent of adults have thyroid nodules, even though most people never know they have them and will never experience any symptoms or problems from these growths.
  2. Thyroid nodules are four times more common in women than in men, and the likelihood of developing them increases with age, meaning that by age sixty, approximately half of all people will have at least one nodule.
  3. In countries where iodine deficiency was historically common, the introduction of iodized salt dramatically reduced thyroid nodule prevalence—the United States virtually eliminated iodine deficiency disorders after introducing iodized salt in 1924.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Benign neoplasm of thyroid gland

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Thyroid mass+4

Not yet recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Iodide (131I)
  • Sponsor:Rijnstate Ziekenhuis Stichting
See all 1 trials →filters applied: condition = Benign neoplasm of thyroid gland

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).